{"id":473906,"date":"2024-04-01T10:02:42","date_gmt":"2024-04-01T08:02:42","guid":{"rendered":"https:\/\/innovationorigins.com\/?p=473906"},"modified":"2024-04-01T10:02:42","modified_gmt":"2024-04-01T08:02:42","slug":"sbmc-high-tech-nl-and-bom-join-forces-for-biomedical-innovation","status":"publish","type":"post","link":"https:\/\/ioplus.nl\/archive\/en\/sbmc-high-tech-nl-and-bom-join-forces-for-biomedical-innovation\/","title":{"rendered":"SBMC, High Tech NL, and BOM join forces for biomedical innovation"},"content":{"rendered":"\n

Smart BioMaterials Consortium (SBMC), High Tech NL, and the Brabant Development Agency (BOM) are collaborating to accelerate innovations in regenerative medicine. Juliette van den Dolder has been appointed as an Innovation Designer. Her goal is to accelerate the development of production technology for regenerative therapies and connect the SBMC ecosystem with the NXTGEN Hightech program \u2018biomedical production technology<\/em>\u2019, supported by High Tech NL.<\/p>\n\n\n\n

\u201cScaling up and bringing regenerative therapies to market cannot be done without the right production technology,\u201d says Jan Rietsema, director of SBMC. SBMC has one area of expertise, and NXTGEN Hightech has the other. Therefore, Rietsem says, “it is crucial that the ecosystems around both organizations can complement each other well. The new partnership is also good news for companies like LifeTec Group, Vivolta, Stentit, and Xeltis, already collaborating with SBMC and NXTGEN Hightech.”<\/p>\n\n\n

<\/a>
<\/div><\/div>
\u20ac4 million from Smart BioMaterials Consortium for pilot production of biomaterials at High Tech Campus Eindhoven<\/div>
Smart BioMaterials Consortium (SBMC) and High Tech Campus Eindhoven are setting up a pilot production facility for smart biomaterials. <\/div><\/div><\/div>\n\n\n

There is tremendous value in companies within the ecosystem knowing how to find each other, adds Ingrid Relou, Biomedical Production Technology domain leader at NXTGEN Hightech. \u201cThe collaboration with SBMC contributes to developing even better and more widely applicable production technologies.\u201d<\/p>\n\n\n\n

According to Willem Endhoven, director of High Tech NL, the new collaboration aims to increase the Netherlands’ earning capacity. \u201cThis aligns well with the goal of the National Growth Fund, the main funder of SBMC and NXTGEN Hightech.\u201d <\/p>\n\n\n

<\/a>
<\/div><\/div>
Another major investment round for Xeltis: \u20ac32 million for the development of restorative cardiovascular devices<\/div>
Xeltis, a clinical stage medtech company developing living implants that enable the body to restore cardiovascular function, has raised \u20ac32 million in a Series D.<\/div><\/div><\/div>\n\n\n

Biomaterials<\/h2>\n\n\n\n

Biomaterials have been used for decades to replace or repair damaged tissues and organs, and the development of new materials has been a major focus in biomedical engineering. Recently, the use of smart biomaterials has emerged as a promising field that could revolutionize the way we treat diseases and injuries. Smart biomaterials are able to respond to environmental stimuli, enabling them to interact with biological systems in a controlled manner.<\/p>\n\n\n

<\/a>
<\/div><\/div>
Thanks to VivArt-X’s regenerated breast tissue, life for women after mastectomy gets a lot better<\/div>
Many good ideas arise from surprise or even frustration with an existing situation. Such was the case at VivArt-X. <\/div><\/div><\/div>\n\n\n

Smart biomaterials have a wide range of potential applications in biomedicine. Some of the most promising areas of research include:<\/p>\n\n\n\n